TRLPC: Surging M&A boosts US bridge loan issuance

NEW YORK, July 29 (Reuters) - Massive acquisition financings are multiplying. Israeli pharmaceuticals firm Teva Pharmaceutical Industries is lining up $27 billion of debt to finance its $40.5 billion acquisition of Allergan's generics business, following hard on the heels of a similar $26.5 billion, 364-day facility backing U.S. health insurer Anthem's $54.2 billion acquisition of health services company Cigna Corp.